key: cord-0775180-56qlfswo
authors: Du, Xiaohong; Tang, Haijun; Gao, Long; Wu, Zhao; Meng, Fang; Yan, Ruhong; Qiao, Shigang; An, Jianzhong; Wang, Chen; Qin, F. Xiao-Feng
title: Omicron adopts a different strategy from Delta and other variants to adapt to host
date: 2022-02-10
journal: Signal Transduct Target Ther
DOI: 10.1038/s41392-022-00903-5
sha: be77dc4c58afd11f967409e51c6e0a2e155bc254
doc_id: 775180
cord_uid: 56qlfswo

nan

the difference in Furin-related cleavage, deletion of Furin site made most SARS-CoV-2 virus to enter via E64d-sensitive path, and made it like SARS-CoV-1 (Fig. 1a, Supplementary Fig. 2c-e) . Moreover, similar with Delta, 12 mutations of Omicron S protein to basic amino acid (K, R, H) generate more amino groups (-NH3+), promoting protonation and sensitivity to endosomal hydrolytic enzymes, such as cathepsin B/L. Overall, Omicron S protein favors endocytic entry path in contrast to Delta and other variants.

Because of the P681R mutation, Delta variant obtains powerful fusogenicity and pathogenicity. 1 To quantitatively characterize the fusogenicity, the split GFP/renilla luciferase (Rluc8) reporter system was used to monitor the dynamic of cell-cell fusion mediated by S and ACE2. Delta, Lambda, and P681H/R S proteins showed the most powerful fusogenicity, while Mu and Omicron variants were weaker than WT and D614G in despite of P681H mutation (Fig. 1h , Supplementary Fig. 3a, b) . Interestingly, Alpha S protein had similar Furin-related cleavage with Omicron, but had similar fusogenicity with WT and D614G, implying some undefined mutations (e.g., N679K, N856K, Q954H, N969K, and L981F) surrounding the S1/S2, S2' cleavage sites and heptad repeat 1 (HR1) in Omicron S protein regulate the membrane fusion. Moreover, the fusion rate of Omicron was the slowest in all SARS-CoV-2 variants, making it similar with SARS-CoV-1 (Fig. 1h , Supplementary Fig. 3a, b) . Data from another cell-cell fusion reporter system mediated by T7 polymerase also demonstrated the similar tendency ( Supplementary Fig. 3c, d) .

Given the report that the cell-cell fusion mediated by S protein and ACE2 could induce the pyroptosis to exacerbate excessive inflammatory responses, 2 we speculated that the fusogenicity change could alter the pro-inflammatory effect of Omicron S protein. Reporter assay demonstrated that, compared with WT and D614G, S protein of Delta, Lambda, and Mu variants significantly activated NF-κB pathway (Fig. 1i , Supplementary  Fig. 4a, b) . Reassuringly, Omicron variant only slightly promoted the activation of NF-κB pathway, which is consistent with early reports that Omicron infected patients and animals show relative mild symptoms. 3, 4 Moreover, the activation of NF-κB pathway was boosted by TMPRSS2, implying the syncytial formation was the leading cause of pro-inflammatory pathway activation (Supplementary Fig. 4c ).

Due to the heavy mutation in Omicron S protein, the tendency of immune escape from existed protection of vaccination is worrisome. So, we collected fourteen sera from volunteers who have received two doses of inactivated SARS-CoV-2 vaccines (CoronaVac and BBIBP-CorV) ( Supplementary Fig. 5a) . Compared with D614G, the neutralizing antibody titer for Lambda, Mu, and Omicron variants decreased 1.5, 6.0, and 13.9 times, respectively (Fig. 1j, k, Supplementary Fig. 5b) , explaining the reason why so many confirmed cases have already got fully vaccinated. 3 Meanwhile, the protection of monoclonal neutralizing antibodies (mNAbs) for Mu and Omicron variants was also destroyed ( Fig. 1l, Supplementary Fig. 5c ). Alarmingly, Omicron variant fully escaped from the protection of all ten mNAbs targeting receptorbinding domain (RBD), highlighting the importance of implementing strict epidemic prevention policies and developing cocktail therapies and Omicron-specific vaccines. 5 In this report, we systematically characterized the infectivity, thermal stability, proteolytic activation, entry path, fusogenicity, and immune response of newly emerging SARS-CoV-2 variants, and identified Omicron as a unique strain with different evolutionary strategies from previous strains to adapt to host (Fig. 1m ).

First, in contrast with Delta and other variants, Omicron favors cathepsin-dependent (E64d-sensitive), but not TMPRSS-like proteasesdependent (Camostat-sensitive) entry path. These findings could explain the change of viral tropism in host tissues and cells with different TMPRSS-like protease level, and suggest combination of TMPRSS-like and cathepsin inhibitors as a reliable treatment for all SARS-CoV-2 variants. Second, in despite of P681H mutation, fusogenicity of Mu and Omicron are significantly weaker than other variants. Third, consistent with fusogenicity, pro-inflammatory effect of Omicron S protein is tempered. Fourth, the heavy mutations give Mu and Omicron variants the strongest ability ever to escape immune protection from vaccination and mNAbs. All these characters of Omicron make it different from Delta and other variants, empowering it to broadly transmit among fully vaccinated population, and changing the tropism and clinical symptoms. To combat against Omicron and other future variants, combination of multiple treatment modalities could be a better and more reliable therapeutic strategy, and variant-specific and pan-β-coronavirus NAbs and vaccines also are the potential prophylactic and therapeutic approaches. Overall, S protein mutations in Lambda, Mu, and Omicron variants alter the infectivity, fusogenicity, and immune response, severely threatening the current therapeutic and prophylaxis approaches, highlighting the importance of implementing strict epidemic prevention policies.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons. h The dynamic of cell-cell fusion mediated by ACE2 and variants S proteins. i The NF-κB reporter activation mediated by incubation with variants S proteins expressing 293T cells. j, k The neutralization of variants pseudovirus by sera from 14 volunteers received two doses of inactivated SARS-CoV-2 vaccines. The numbers indicate change of geometric mean titers compared with D614G reference virus. l The neutralization of variants pseudoviurs by 10 mNAbs targeting RBD of S protein. BDL indicates neutralizing activity below the detection limit when tested at the highest concentration. m The radar chart of characters of variants. Experiments were done in 3-4 replicates and repeated at least twice. One representative is shown with error bars indicating SEM

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells

Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves

Reduced pathogenicity of the SARS-CoV-2 Omicron variant in hamsters

SARS-CoV-2 Omicron variant: characteristics and prevention